中国寄生虫学与寄生虫病杂志 ›› 2013, Vol. 31 ›› Issue (2): 4-99-103.

• 论著 • 上一篇    下一篇

西咪替丁伍用弓形虫ROP2蛋白免疫小鼠诱导免疫反应的初步研究

陈兴智1,2 *,杨小迪1,杨雯1,陈勇1,刘丽丽2,沈继龙2,孙新1   

  1. 1 蚌埠医学院病原生物学教研室,安徽省感染与免疫重点实验室,蚌埠 233030;2 安徽病原生物学省级实验室,人兽共患病安徽省重点实验室,安徽医科大学病原生物学教研室,合肥 230032
  • 出版日期:2013-04-30 发布日期:2013-07-02

Study on Immune Response in BALB/c Mice Induced by ROP2 Protein of Toxoplasma gondii with Cimetidine

CHEN Xing-zhi1,2 *, YANG Xiao-di1, YANG Wen1, CHEN Yong1, LIU Li-li2, SHEN Ji-long2, SUN Xin1   

  1. 1 Department of Microbiology and Parasitology,Bengbu Medical College;Anhui Key Laboratory of Infection and Immunity,Bengbu 233030,China;2 Provincial Laboratory of Microbiology & Parasitology and Key Laboratory of Zoonoses;Department of Parasitology, Anhui Medical University, Hefei 230032, China
  • Online:2013-04-30 Published:2013-07-02

摘要: 目的  观察西咪替丁伍用弓形虫棒状体蛋白2(ROP2)免疫小鼠诱导的免疫反应。 方法  80只BALB/c小鼠随机分为A组、B组、C组和D组,各组分别经皮下注射PBS、弓形虫ROP2蛋白+PBS、弓形虫ROP2蛋白+福氏佐剂和弓形虫ROP2蛋白+西咪替丁[200 mg/(kg·d)]免疫BALB/c小鼠,每次ROP2蛋白免疫剂量为100 μg/只(200 μl),共免疫3次,每次间隔2周。于首次免疫前和每次免疫后2周,采血分离血清。末次免疫后2周,每组小鼠随机处死8只,无菌分离脾细胞,CCK-8法测定淋巴细胞增殖活性。流式细胞术检测小鼠全血T细胞亚群。ELISA法检测小鼠血清IgG抗体和γ干扰素(IFN?鄄γ)水平。各组剩余12只小鼠经腹腔感染弓形虫RH株速殖子(5×104个/鼠),观察攻击感染后小鼠生存时间。  结果  末次免疫后2周,A、B、C和D组小鼠的血清IFN-γ水平分别为(659.750±239.962)、(872.750±197.011)、(1600.750±480.680)和(1 494.375±451.655)pg/ml,血清特异性IgG抗体水平分别为0.504±0.078、0.592±0.160、1.068±0.111和1.046±0.147,脾细胞增殖活性分别为0.504±0.078、0.592±0.160、0.831±0.130和0.762±0.089,外周血CD4+/CD8+比值分别为0.504±0.078、0.592±0.160、0.831±0.130和0.762±0.089,C和D组均显著高于A和B组(前3个指标,均P<0.01;后者,均P<0.05),D组与C组的差异均无统计学意义(P>0.05)。各免疫组弓形虫攻击感染后,A、B、C 和D 组小鼠的生存时间中位数分别为96、108、132和132 h,C组和D组小鼠平均存活时间显著长于A组和B组(P<0.05),D组与C组的相比,差异无统计学意义(P>0.05)。  结论  西咪替丁可增强ROP2蛋白诱导的细胞免疫和体液免疫反应。

关键词: 刚地弓形虫, 西咪替丁, 棒状体蛋白2, 免疫反应, 蛋白疫苗

Abstract: Objective  To observe the immune response induced by ROP2 protein of Toxoplasma gonddi with cimetidine in mice.  Methods  Eighty BALB/c mice were randomly divided into 4 groups: PBS(group A), ROP2 protein (group B), ROP2 protein-Freund’s adjuvant (group C) and ROP2 protein-cimetidine(group D). Mice were immunized with PBS, ROP2 protein, ROP2 protein and Freund’s adjuvant, ROP2 protein and cimetidine[200 mg/(kg·d)] by subcutaneous injection three times at an interval of 2 weeks, respectively. Experimental mice were immunized with 100 μg ROP2 proteins, which were diluted to a final volume of 200 μl in PBS. On day 13, 27 and 41 after immunization, mice sera were collected for determination of antibody IgG and cytokine IFN-γ by ELISA. Two weeks after the final immuni-zation, T cells subpopulation was detected by flow cytometry and splenocyte proliferation activity was determined with CCK-8. Another 12 immunized mice in each group were intraperitoneally challenged with 5×104 tachyzoites of T. gondii and the survival time was observed.  Results  Two weeks after final immunization, compared with groups A[(659.750±239.962) pg/ml] and B [(872.750±197.011) pg/ml], the level of IFN-γ significantly increased in groups C [(1 600.750±480.680) pg/ml] and D [(1 494.375±451.655) pg/ml] (P<0.01). Similarly, compared with groups A (0.636±0.108) and B (0.871±0.089), the level of IgG was also higher in groups C(1.068±0.111) and D(1.046±0.147) (P<0.01). The proliferation of splenocytes rose in group C(0.831±0.130) after immunization, and similarly in group D (0.762±0.089), and were both significantly higher than that of groups A (0.504±0.078) and B (0.592±0.160)(P<0.01). Moreover, ratio of CD4+/CD8+ in groups C (0.831±0.130) and D (0.762±0.089) were higher than that of groups A(0.504±0.078) and B(0.592±0.160)(P<0.05). After challenge with violent virulence strain of tachyzoites, the median survival time of mice in groups A, B, C, and D were 96, 108, 132, and 132 h, respectively. The mean survival time of mice in groups C and D were longer than that of groups A and B(P<0.05). There was no significant difference in 5 parameters between C and D: the level of IFN-γ and IgG, CD4+/CD8+ ratio, splenocyte proliferation, and survival time of mice(P>0.05).  Conclusion  Cimetidine can enhance the humoral and cellular immune response induced by ROP2 protein.

Key words: Toxoplasma gondii;Cimetidine, Rhpotry protein 2;Immune response;Protein vaccine